Viewing Study NCT03079505


Ignite Creation Date: 2025-12-25 @ 3:33 AM
Ignite Modification Date: 2026-04-24 @ 3:54 AM
Study NCT ID: NCT03079505
Status: TERMINATED
Last Update Posted: 2019-01-23
First Post: 2017-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dasatinib Versus Nilotinib for Treatment Naïve Chronic Myeloid Leukemia
Sponsor: Hamad Medical Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module